Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-25T19:17:20.511Z Has data issue: false hasContentIssue false

A psychiatrist's perspective from a COVID-19 epicentre: a personal account

Published online by Cambridge University Press:  09 September 2020

Isabella Pacchiarotti
Affiliation:
Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain
Gerard Anmella
Affiliation:
Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain
Giovanna Fico
Affiliation:
Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain
Norma Verdolini
Affiliation:
Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain
Eduard Vieta*
Affiliation:
Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain
*
Correspondence: Eduard Vieta. Email: evieta@clinic.cat
Rights & Permissions [Opens in a new window]

Abstract

Background

The COVID-19 pandemic has and will have a huge impact on mental health, especially in countries that have been significantly affected, such as Spain.

Aims

Here we aim to provide the perspectives of a group of psychiatrists from Barcelona, one of the epicentres of the pandemic so far, to highlight the potential fatality of a virus that caught us unaware and unprepared, and hopefully this article will be of aid to countries about to face the pandemic.

Results

The unprecedented situations that we have been faced with so far have included reconfiguring hospitals and the redeployment of healthcare professionals, with flexibility and adaptability key to managing the overload in demand. This has led to healthcare professionals being exposed to extremely stressful situations and they have had impossible decisions to make that may have mental health consequences, some of which may be severe and long lasting.

Conclusions

A rebound effect on mental health problems is to be expected in the medium and long term, especially for healthcare professionals and psychiatric patients, necessitating a strengthening of preventive approaches and policies for mental health along with a prompt reopening of mental health services. Ways to provide psychiatric healthcare in the immediate future need to be re-evaluated, and the development of telepsychiatry services is probably to be expected.

Type
Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

The Coronavirus disease 2019 (COVID-19) pandemic, with more than 12 million cases and 500 000 deaths reported worldwide,1 has and will have a huge impact on mental health, especially in those countries most affected, such as Spain.

Here we provide the perspectives of a group of psychiatrists from Barcelona, one of the epicentres of the pandemic so far, to highlight the potential fatality of a virus that has caught us unaware and unprepared, and we hope this article will be of value to countries about to face the pandemic.

Results

The COVID-19 outbreak: Europe unaware?

In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China.Reference Lu, Stratton and Tang2 At the time of writing, almost 150 days later, more than 4 500 000 infections have been confirmed worldwide in the COVID-19 pandemic, with an approximate mortality of 7%.3 Worldwide a number of different public health responses have been used to attempt to contain the pandemic,Reference Tanne, Hayasaki, Zastrow, Pulla, Smith and Rada4 with China imposing the first complete lockdown on the 23 January 2020, with 571 officially confirmed cases and 17 deaths.5

Despite the successful policies used in Asian countries to contain the spread of COVID-19, Europe failed to recognise the magnitude of the pandemic. Many European countries did not promptly deliver a coordinated response as the crisis was unfolding. Indeed, the government of Italy imposed lockdown on the 8 March 2020, with 5800 confirmed cases and 233 deathsReference Davidson6 and the Spanish government declared a state of emergency and imposed a lockdown on the 14 March 2020 with 6251 confirmed cases and 193 deaths.Reference Jones7 Many Spanish scientists have criticised the insufficient measures taken to contain the spread of the virus, claiming to cause Spain's move from partial to complete lockdown.Reference Mitjà, Arenas, Rodó, Tobias, Brew and Benlloch8 This was probably because of a generalised underestimation of SARS-CoV-2 and overconfidence from European governments, which were sceptical about the initial need for state-of-emergency declarations. To add fuel to the fire, many social mass gatherings were held all over Europe in the weeks and days before Italy and Spain imposed lockdownsReference Oltermann9 despite it being clear that the dynamics behind the virus's rapid exponential expansion worldwide had relied heavily on social gatherings. These events appear to have been conducted with astounding connivance and silence from the political sector. The later exponential escalation in cases and deaths in Italy and Spain leave to doubt if all this could have been prevented.

Healthcare system upside-down: unprecedented measures for unprecedented situations

The aftermath of the probably insufficient preventive public health policies implemented by Italy and Spain has led to more than 240 000 cases and 28 000 deaths from COVID-19 in each of these countries, respectively, leading the world ranking (at the time of writing the first draft of this manuscript, 2 May 2020).10 The epidemic curve for confirmed cases of COVID-19 in Spain, according to clinical severity, can be seen in Fig. 1 and the geographical distribution of COVID-19 confirmed cases by autonomous community is reported in Fig. 2.

n, the cases per day are represented according to the date at the onset of symptoms, date of hospital admission and date of ICU admission, and deaths according to the official dates of death. Each line reports trends with moving averages for 7 days. Source: Informe n° 32. Situación de COVID-19 en España a 21 de mayo de 2020. Equipo COVID-19. Red Nacional de Vigilancia Epidemiológica (RENAVE). Centro Nacional de Epidemiología (CNE). Centro Nacional de Microbiología (CNM). Instituto de Salud Carlos III (ISCIII).11 Data updated on the 21 May 2020.

Fig. 1 The epidemic curve for COVID-19 confirmed cases in Spain according to clinical severity.

Source: data for COVID-19 cases reported by the Spanish Ministry of Health, Consumer Affairs and Social Welfare.12,13 Data updated on the 17 May 2020.

Fig. 2 Geographical distribution by autonomous community in Spain for the total number of confirmed cases of COVID-19.

Several major public health measures were urgently adopted by most countries to reduce spread, including forced quarantine and restructuring of health systems, with the redeployment of healthcare professionals from all disciplines to COVID-19 units, following assistance requirements.Reference Tanne, Hayasaki, Zastrow, Pulla, Smith and Rada4

This exponential growth in a matter of days put public healthcare systems under severe stress, with hundreds of new cases of complicated COVID-19 arriving in the emergency rooms of most hospitals with insufficient admission capacity and intensive care unit (ICU) beds in public health systems that were already usually working at nearly full capacity.

As a representative model, the Hospital Clínic of Barcelona has been ‘literally’ turned upside-down with the unceasing overflow of patients with COVID-19 arriving in the emergency room and requiring admission in the weeks after lockdown. The lack of enough room to admit these patients brought about the creation of a ‘crisis cabinet’ to lead a full restructuring, by transforming day hospitals, dialysis rooms and operating rooms into ICUs. A total of 42 ICU beds were occupied in only 48 h, and at the peak of the pandemic outbreak a total of 11 ICUs were active, with 110 occupied ICU beds. Moreover, the internal medicine and infectious diseases hospitalisation units were overcrowded and a total of 16 hospitalisation units were cleared by discharging less-severe hospitalised patients and converting these units into COVID-19 units.

Non-urgent surgical activities and out-patient medical appointments were postponed. Hospital hallways and unprepared hospitalisation rooms were provided with oxygen supplies and improvised into COVID-19 facilities, and libraries were transformed into medical equipment warehouses. Other unprecedented measures were also taken, such as refurbishing a nearby hotel to transform it into an extension of the hospital with the capacity to treat 300 patients with COVID-19 including fitting it out with oxygen supplies, a hospital pharmacy and an x-ray machine. In sum, the Hospital Clínic of Barcelona was completely reconfigured in a few days, tripling its ICU beds and attending, simultaneously, to a total of 900 in-patients with COVID-19: 600 in-patients (110 in ICU) and up to 300 on home hospitalisation (which includes home visits by a medical team and tele-monitoring).14

Healthcare professionals: the high cost of good clinical practice

Besides the aforementioned structural changes to healthcare facilities, healthcare professionals from all disciplines have been involved in the restructuring in several ways: many have been redeployed in novel COVID-19 hospitalisation units or even transferred to different cities based on assistance requirements, and many healthcare specialists have had to rebrand and update themselves into the infectious-respiratory field of medicine because of the lack of sufficient trained professionals.Reference Tanne, Hayasaki, Zastrow, Pulla, Smith and Rada4

Thus, healthcare professionals, especially those on the frontline, who have been at greater risk of being infected,15 have been exposed to unprecedented stress, facing increased workload and great emotional burden. Their concerns about the risks of infection and developing complications, and the constant fear of spreading the virus to their families at home and colleagues, has exposed them to greater isolation measures with worse psychological outcomes.Reference Xiang, Yang, Li, Zhang, Zhang and Cheung16,Reference Belingheri, Paladino and Riva17 Indeed, healthcare professionals are highly vulnerable to experiencing physical exhaustion, fear, emotional disturbance, stigmatisation, insomnia, depression and anxiety, distress, substance use, post-traumatic stress disorder (PTSD) symptoms, and even suicide.Reference Lai, Ma, Wang, Cai, Hu and Wei18Reference Lu, Wang, Lin and Li21 A recent study on frontline healthcare professionals in Italy, reported rates of almost 50% for PTSD symptoms, 25% for severe depression and 20% for anxiety and insomnia.Reference Salazar de Pablo, Vaquerizo-Serrano, Catalan, Arango, Moreno and Ferre22 Additionally, a potential increase in brief reactive psychosis in healthcare professionals because of the COVID-19 outbreak has recently been reported.Reference Anmella, Fico, Roca, Gómez, Vázquez and Murru23 This emphasises the need for urgent mental health preserving strategies for healthcare professionals during the current pandemic.Reference Pfefferbaum and North24

Healthcare professionals have been also implicated as ‘super-spreaders’ with nosocomial origins of infection being a key component in community propagation of SARS-CoV-2. The lack of personal protective equipment (PPE), such as gloves or masks, has been a recurring problem in many regions of Italy and Spain during the first phase of the crisis and raised the ethical dilemma of beneficence and non-maleficence. When not enough PPE is available, should healthcare professionals continue to offer treatment on deontological grounds or refuse on the grounds that becoming a ‘super-spreader’ would be more harmful to society? This is still a matter of debate, and one in which healthcare professionals should preserve their right to make their own personal decision.Reference Singh and Longstaff25 However, in real-world practice during this pandemic, and especially in countries like Spain or Italy, it would be inconceivable not to provide treatment for a net societal good, so this important debate has taken place on a theoretical basis and has been so far been drowned out by healthcare authorities claiming the principle of beneficence, and most professionals have felt compelled to work sometimes under unprotected conditions.

Several members of our team, including some of the authors, were relocated and redeployed to aid with direct or indirect medical attention for patients with COVID-19 and one of them was exposed in the frontline (in a newly converted COVID-19 hospitalisation unit). The uncertainty surrounding every aspect of the COVID-19 outbreak was a key aspect contributing to suffering. We did not know the magnitude of the catastrophe that was to be expected, nor the length of time that we were going to be in that situation, or even sometimes, what to do, what to tell our families, or how to support our colleagues and loved ones. At some points, while blinded by uncertainty, only the quote by Winston Churchill shed some light: ‘Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning’.Reference Churchill26

Several members of our team experienced the burden of having to take on major responsibilities because of unprecedented, and sometimes impossible, decisions such as: how to organise the acute psychiatric hospital unit with insufficient COVID-19 detection and protection methods both for in-patients and healthcare professionals. This huge emotional load, which lasted for more than 2 months during the peak of the pandemic, has taken a toll on many members of our team, who have experienced stress-related symptoms. However, subsequent evaluations from many team members agree that the supportive and collaborative atmosphere that was created back then has been key to preventing many healthcare workers from collapse.

Mental health consequences in the general population: dear lockdown

The current pandemic is also leading to negative psychological effects in the general population.Reference Sim, Chua, Vieta and Fernandez27,Reference Fullana, Hidalgo-Mazzei, Vieta and Radua28 Among stressors, fear of infection, a longer quarantine, isolation or movement restrictions, lack of information, financial loss, inadequate supplies and stigma all contribute to deterioration in psychological outcomes. At such times, keeping the general public informed about protocols is essential and supplies should be ensured.Reference Brooks, Webster, Smith, Woodland, Wessely and Greenberg29 Lockdown, isolation, movement restriction and/or quarantine, may have a substantial and long-lasting negative psychological impact on the general population, so it needs to be handled carefully. The reported negative psychological effects include feelings of anger, frustration, boredom and guilt, post-traumatic stress symptoms, confusion, insomnia and suicide. However, many people may present with persistent and/or delayed effects in the form of anxiety disorders and depression.Reference Vieta, Pérez and Arango30

More severe mental health problems may arise from the current crisis as stressful events in adult life have been shown to increase up to threefold the risk of psychosis in previously healthy individualsReference Beards, Gayer-Anderson, Borges, Dewey, Fisher and Morgan31 and preliminary evidence points to an increase in first-episode psychosis in the months since the outbreak of the pandemic.Reference Kozloff, Mulsant, Stergiopoulos and Voineskos32 Recent evidence from a hospital in southern Spain suggests, over a short period of time, there has been an increase in brief reactive psychotic disorders in previously healthy populations directly triggered by stress related to the pandemic.Reference Valdés-Florido, López-Díaz, Palermo-Zeballos, Martínez-Molina, Martín-Gil and Crespo-Facorro33

In addition to the effects caused by lockdown, many people are likely to experience the effects of another particular feature of the current pandemic – the cruelty of isolation from caring for relatives who are dying because of their infection with COVID-19. This carries intrinsic suffering both for dying people and their close relatives and may leave sequelae in the form of pathological mourning. To prevent it, communication between patients and their families should be offered as frequently as possible. In this regard, psychologists are playing a fundamental role in many hospitals. In our unit, the psychology team has led an initiative to facilitate communication between patients with COVID-19 and their families by video calls with the nursing teams. Another initiative has been the psychological team working in shifts every day providing supportive care for patients with COVID-19 and their relatives. They have also issued several recommendations for dealing with grieving families and are working together with several healthcare teams for training, but also to provide support for healthcare professionals struggling with the whole situation, in collaboration with the consultation-liaison psychiatry (CLP) unit. Preventive strategies must be prepared to help identify high-risk individuals in the early stages of complicated grief that emerge from the current pandemic.Reference Arango34

Psychiatric populations: where and how are our patients?

People with mental disorders are both direct and indirect victims of the pandemic.Reference Bo, Li, Yang, Wang, Zhang and Cheung35,Reference Yao, Chen and Xu36 They may be more susceptible to infections, including pneumoniaReference Seminog and Goldacre37 for a variety of reasons including cognitive impairment, negligence relating to risks, confinement conditions on psychiatric wards, restrictions in regular out-patient evaluations, pharmacological treatment and unequal access to healthcare settings.

At the peak of the pandemic in Spain, as mentioned above, many specialties were forced to reconfigure their wards in order to treat patients with COVID-19. Hospital psychiatric units were not unaffected, and several acute in-patient units have been converted and others have seen their admission capacity reduced. In our centre, the child and adolescent in-patient psychiatric unit with 21 beds was converted into a COVID-19 unit; the adult psychiatric in-patient unit's capacity for admission was reduced by 50% (to isolate and test susceptible patients for SARS-CoV-2 infection); the psychiatric emergency room was converted for terminally ill patients with COVID-19 who were not candidates for ICU; and the day hospital with a capacity for 16 patients was closed. Although we have been trained to operate on the bases of the principles of distributive justice, equity, autonomy and recovery, we were forced to give assistance prioritising those with the most severe conditions.

With these shortages in several (often considered essential) units providing psychiatric medical attention, one would have expected an increase in the psychiatric demand in the emergency room. However, there was a clear reduction in the number of emergency room visits, as well as hospital admissions for patients with psychiatric disorders. This has posed the question: ‘where and how are our patients?’.

This decrease in attendances has also occurred for other non-psychiatric medical conditions, such as strokes and heart attacks, where individuals are seen in the emergency room much later than usual and with more serious symptoms. The plausible explanations for the drop in demand for medical attention include the fear of infection and the mandatory confinement. However, even with the drop in demand, we find ourselves in a highly stressful situation with lockdown being a source of stress and anxiety, and patients with psychiatric pathologies are particularly vulnerable and may present relapses. This situation can be particularly stressful for children with neurodevelopmental disorders, such as autism spectrum disorders or intellectual disability that need a daily routine and may be particularly affected if they or their caregivers become infected because of the need for isolation.Reference Liu, Bao, Huang, Shi and Lu38 Patients with schizophrenia, bipolar disorder, and other severe mental disorders may also be more vulnerable and individuals with substance use disorders may experience withdrawal syndrome because of difficulty obtaining drugs, whereas other addictions, such as alcoholism, smoking and online gambling may worsen.Reference Stefana, Youngstrom, Chen, Hinshaw, Maxwell and Michalak39

Furthermore, patients with mental disorders are often stigmatised40 and it has also been reported41 that COVID-19 can be associated with a higher risk of stigmatisation.Reference Kaufman, Petkova, Bhui and Schulze42 Thus, psychiatric patients with COVID-19 could be subjected to a double stigma, that might lead to reduced access to medical services, social isolation and worst health outcomes.Reference Henderson, Noblett, Parke, Clement, Caffrey and Gale-Grant43

Towards a new psychiatry in times of pandemic

As psychiatrists, we are exposed to new challenges. First, many psychiatrists have been recruited as general hospital doctors in healthcare teams dealing with COVID-19. This has reminded us of the value of basic medical training for those working in psychiatry. Our general medical knowledge is essential and may be required, thus psychiatry should be recognised as an equally considered medical specialty.Reference Vieta, Pérez and Arango30

In psychiatric practice, to compensate for the shortages in several psychiatric units, other alternatives have been strengthened: mental health home care and home hospitalisation care (which includes home visits by a medical team and tele-monitoring) has been proposed as an alternative in order to avoid psychiatric hospital admissions, to ensure regular administration of long-acting injectable antipsychotic medications and to provide continuous monitoring of laboratory parameters during psychopharmacological treatment, including the tests required for patients treated with lithium and clozapine.Reference Garriga, Agasi, Fedida, Pinzón-Espinosa, Vazquez and Pacchiarotti44

Another compensatory measure that has been adopted in psychiatry as well as in many medical specialties is a transition to telemedicine with out-patient tele-visits (via telephone, chat or video call).Reference Shore, Schneck and Mishkind45 Mental health seems a good candidate for telemedicine as a physical examination is not always required.Reference Hollander and Carr46 So far, during the pandemic, it has been a practical alternative and many problems have been solved this way, especially for patients who have been followed-up for some time already and who are able to maintain a close relationship with their therapists this way.Reference Torous and Wykes47 However, much psychopathological information might be lost and new consultations, in particular, are hampered by telepsychiatry. In the post-COVID-19 scenario, mental health is probably going to benefit from the increasingly important role of m-health (mobile health),Reference Hidalgo-Mazzei, Murru, Reinares, Vieta and Colom48,Reference Hidalgo-Mazzei, Young, Vieta and Colom49 which may serve as an instrument for case management and patient empowerment.Reference Hidalgo-Mazzei, Llach and Vieta50

Following the hospital conversions, CLP units have gained prominence. Our CLP unit (usually consisting of two psychiatrists) has been reinforced with more than seven psychiatrists at the peak of the pandemic. The unit faced challenges in the psychopharmacological management of patients relating to potential interactions of psychotropic medications with experimental COVID-19 therapies.51 As a result of the complexity of real-world clinical scenarios and the lack of case-centred recommendations, our CLP unit has issued practical recommendations for the psychopharmacological management of the most representative case scenarios that we have identified regarding patients who were admitted to hospital with COVID-19 who had psychiatric disorders, based on existing literature and clinical experience.Reference Anmella, Arbelo, Fico, Murru, Llach and Madero52

Another matter of concern has been what to do with patients requiring a psychiatric admission but who are also infected with SARS-CoV-2 (but who do not require admission because of respiratory problems). This has led to strict control of patients who need admission for psychiatric reasons using polymerase chain reaction-based tests and admissions into either (a) ‘clean’ psychiatric in-patient units; (b) ‘COVID-19’ psychiatric units, or (c) non-psychiatric COVID-19 hospital units with the support of CLP units. When a patient requires a psychiatric admission and is also infected by SARS-CoV-2, this poses several problems relating to the need for isolation, which may be difficult for patients with those psychiatric conditions that include behavioural changes (such as disorganised behaviour and altered judgement during severe psychotic episodes), or those who disrespect social distancing in manic states etc. These situations may pose additional risk for patients and healthcare professionals.

Discussion

Future perspectives: making mental healthcare essential

Predictive models suggest that after this current, most severe pandemic, wave recurrent outbreaks of SARS-CoV-2 will probably occur. In Spain, after the peak of the pandemic (Fig. 3), several COVID-19 resurgences have been arising on a local basis (Fig. 4). Therefore, unless critical care capacity is increased substantially or a vaccine becomes available, prolonged or intermittent social distancing has been predicted to be necessary into 2022. Moreover, the duration of acquired immunity to SARS-CoV-2 is unclear and longitudinal serological studies are needed. Predictions suggest that a resurgence in contagion could be possible as late as 2024.Reference Kissler, Tedijanto, Goldstein, Grad and Lipsitch55

The new daily confirmed cases have been divided into two periods according to approval on 11 May 2020 of the new diagnostic, surveillance and control strategy for the ‘transition’ phase of the COVID-19 pandemic. On the left, the first period (from 1 March 2020 to 10 May 2020) showing daily newly diagnosed cases (by polymerase chain reaction (PCR)) and daily cases with positive immunoglobulin (Ig)G antibodies (presumed immunity). On the right, the second period (from 11 May 2020 ongoing until the time of writing on 13 July 2020) showing daily newly diagnosed cases (by PCR or positive IgM antibodies) divided by symptom presentation. Source: Actualización no 160. Enfermedad por el coronavirus (COVID-19). Ministerio de Sanidad - Gobierno de España.52 Data updated on the 9 July 2020.

Fig. 3 Daily confirmed COVID-19 cases in Spain (updated on 09 July 2020).

After the peak of the pandemic in Spain, lockdown and restriction measures have been progressively withdrawn. The state of emergency expired on 21 June 2020, and each autonomous community has been responsible for the detection and management of COVID-19 resurgences since then, which have been arising continuously. The figure shows the focuses of COVID-19 resurgence during epidemiological week 27. Catalonia, in the north-eastern part of the map, includes four provinces (Barcelona, Lleida, Girona and Tarragona). One of them (Lleida) experienced a COVID-19 resurgence in week 27 (160.72 cases/100 000 compared with 9.04 cases/100 000 in Barcelona in the same week), and restriction measures have been applied accordingly by the Catalan Government. Source: Department of Health. Spanish Government. Red Nacional de Vigilancia Epidemiológica (RENAVE). Centro Nacional de Epidemiología (CNE). Centro Nacional de Microbiología (CNM).54 Data updated on the 10 July 2020.

Fig. 4 Cumulative incidences by province in Spain for epidemiological week 27 (29 June to 5 July 2020).

There has been a coordinated response in mental healthcare so far and many of the problems faced have been solved along the way. However, despite all efforts, even if most of the mental health issues caused by the current pandemic may be mild and transient, because of the huge impact in different magnitudes put on the whole population, many will have long-lasting mental health consequences. A rebound effect on mental health problems is expected in the medium and long term, both in people without pre-existing mental health problems (especially in populations at risk, such as healthcare professionals) and in psychiatric patients. This foreseeable increase in demand for psychiatric care highlights the necessity of strengthening preventive approaches and policies in mental health services, including early identification, early treatment and close long-term monitoring of people with the most severe mental health problems; services that have often been marginalised.Reference Arango34

The ongoing process of change in the public health system and the way we interact is raising new questions relating to mental health. As soon as possible after the peak of the pandemic it will be imperative to progressively reopen all mental health resources that have been closed or reduced, to reinforce in-patient and out-patient mental health and primary care services,Reference Vieta, Pérez and Arango30 and to model novel interventions to tackle the current crisis and its consequences.Reference Hidalgo-Mazzei, Llach and Vieta50

Data availability

Data availability is not applicable to this article as no new data were created or analysed in this study.

Author contributions

I.P., G.A. and G.F. formulated this article. I.P., G.A. and G.F. co-wrote the first draft. N.V and E.V. both read the first draft and added critical comments. All authors helped to revise the article and approved the final version and the original submission.

Funding

I.P. is grateful for the support of the Spanish Ministry of Science and Innovation (PI18/01001). G.A.'s research is supported by a Pons Bartran 2020 grant (N° 249566). N.V.'s research is supported by a BITRECS Project, which has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement N° 754550 and from ‘La Caixa’ Foundation (ID 100010434), under the agreement LCF/PR/GN18/50310006. E.V. is grateful for the support of the Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I + D + I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the CIBER of Mental Health (CIBERSAM); the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2017 SGR 1365), the CERCA Programme, and the Departament de Salut de la Generalitat de Catalunya for the PERIS grant SLT006/17/00357.

Declaration of interest

I.P. has received CME-related honoraria, or consulting fees from ADAMED, Janssen-Cilag and Lundbeck and reports no financial or other relationship relevant to the subject of this article. G.A. has received CME-related honoraria, or consulting fees from Janssen-Cilag, Lundbeck and Angelini and reports no financial or other relationship relevant to the subject of this article. G.F. has received CME-related honoraria, or consulting fees from Angelini, Janssen-Cilag and Lundbeck. E.V. reports personal fees from Abbott, personal fees from Allergan, personal fees from Angelini, grants from Dainippon Sumitomo, grants from Ferrer, grants and personal fees from Janssen, personal fees from Lundbeck, personal fees from Sage, personal fees from Sanofi, outside the submitted work.

ICMJE forms are in the supplementary material, available online at https://doi.org/10.1192/bjo.2020.83.

Footnotes

*

Joint first authors.

References

World Health Organization. Coronavirus Disease (COVID-19) Situation Report - 174. WHO, 2020.Google Scholar
Lu, H, Stratton, CW, Tang, Y. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020; 92: 401–2.CrossRefGoogle ScholarPubMed
World Health Organization. Coronavirus Disease (COVID-19) Situation Report-118 Highlights. WHO, 2020.Google Scholar
Tanne, JH, Hayasaki, E, Zastrow, M, Pulla, P, Smith, P, Rada, AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ 2020; 368: 1–5.Google ScholarPubMed
BBC News. China Coronavirus: Lockdown Measures Rise across Hubei Province. BBC News, 2020 (https://www.bbc.com/news/world-asia-china-51217455).Google Scholar
Davidson, H. Coronavirus: quarter of Italy's population put in quarantine as virus reaches The Guardian 2020; 8 March (https://www.theguardian.com/world/2020/mar/08/coronavirus-italy-quarantine-virus-reaches-washington-dc).Google Scholar
Jones, S.Spain orders nationwide lockdown to battle coronavirus. The Guardian 2020; 14 March (https://www.theguardian.com/world/2020/mar/14/spain-government-set-to-order-nationwide-coronavirus-lockdown).Google Scholar
Mitjà, O, Arenas, À, Rodó, X, Tobias, A, Brew, J, Benlloch, JM. Experts’ request to the Spanish Government: move Spain towards complete lockdown. Lancet 2020; 395: 1193–4.CrossRefGoogle ScholarPubMed
Oltermann, P.The cluster effect: how social gatherings were rocket fuel for coronavirus. The Guardian. 2020; 9 April (https://www.theguardian.com/world/2020/apr/09/the-cluster-effect-how-social-gatherings-were-rocket-fuel-for-coronavirus).Google Scholar
World Health Organization. Coronavirus Disease 2019 (COVID-19). Situation Report – 103. WHO, 2020.Google Scholar
RENAVE. Informe no 32. Situación de COVID-19 en España a 21 de Mayo de 2020. Equipo COVID-19. RENAVE. CNE. CNM (ISCIII). Instituto de Salud Carlos III, 2020 (https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx).Google Scholar
Spanish Ministry of Health, Consumer Affairs and Social Welfare. COVID-19 [in Spanish]. Spanish Ministry of Health, Consumer Affairs and Social Welfare, 2020 (https://cnecovid.isciii.es/covid19/).Google Scholar
EL PAÍS. Casos Confirmados de Coronavirus en España y en el Mundo. Sociedad [in Spanish]. EL PAÍS, 2020 (https://elpais.com/sociedad/2020/04/09/actualidad/1586437657_937910.html?ssm=TW_CM).Google Scholar
EL PAÍS. Coronavirus: Un Hospital Patas Arriba Para Contener el Virus. Sociedad [in Spanish]. EL PAÍS, 2020 (https://elpais.com/sociedad/2020-04-15/un-hospital-patas-arriba-para-contener-el-virus.html).Google Scholar
Lancet. COVID-19: protecting health-care workers. Lancet 2020; 395: 922.CrossRefGoogle Scholar
Xiang, YT, Yang, Y, Li, W, Zhang, L, Zhang, Q, Cheung, T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 2020; 7: 228–9.CrossRefGoogle ScholarPubMed
Belingheri, M, Paladino, ME, Riva, MA. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers. J Hosp Infect 2020; 105: 353.CrossRefGoogle ScholarPubMed
Lai, J, Ma, S, Wang, Y, Cai, Z, Hu, J, Wei, N, et al. Factors asociated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020; 3: e203976.CrossRefGoogle Scholar
Liu, S, Yang, L, Zhang, C, Xiang, YT, Liu, Z, Hu, S, et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 2020; 7: e17–8.CrossRefGoogle ScholarPubMed
Kang, L, Li, Y, Hu, S, Chen, M, Yang, C, Yang, BX, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry 2020; 7: e14.CrossRefGoogle ScholarPubMed
Lu, W, Wang, H, Lin, Y, Li, L. Psychologicsal status of medical workforce during the COVID-19 pandemic: a cross-sectional study. Psychiatry Res 2020; 288: 112936.CrossRefGoogle ScholarPubMed
Salazar de Pablo, G, Vaquerizo-Serrano, J, Catalan, A, Arango, C, Moreno, C, Ferre, F, et al. Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis. J Affect Disord 2020; 275: 4857.CrossRefGoogle ScholarPubMed
Anmella, G, Fico, G, Roca, A, Gómez, M, Vázquez, M, Murru, A, et al. Unravelling potential severe psychiatric repercussions on healthcare professionals during the COVID-19 crisis. J Affect Disord 2020; 273: 422.CrossRefGoogle ScholarPubMed
Pfefferbaum, B, North, CS. Mental health and the Covid-19 pandemic. N Engl J Med 2020; 383: 510–2.CrossRefGoogle ScholarPubMed
Singh, A, Longstaff, S. Good Samaritans: An Ethical Perspective during COVID-19. InSight, 2020 (https://insightplus.mja.com.au/2020/16/good-samaritans-an-ethical-perspective-during-covid-19/).Google Scholar
Churchill, W. The End of the Beginning. Cassell and Company, 1943.Google Scholar
Sim, K, Chua, HC, Vieta, E, Fernandez, G. The anatomy of panic buying related to the current COVID-19 pandemic. Psychiatry Res. 2020; 288: 113015.CrossRefGoogle ScholarPubMed
Fullana, MA, Hidalgo-Mazzei, D, Vieta, E, Radua, J. Coping behaviors associated with decreased anxiety and depressive symptoms during the COVID-19 pandemic and lockdown. J Affect Disord 2020; 275: 80–1.CrossRefGoogle ScholarPubMed
Brooks, SK, Webster, RK, Smith, LE, Woodland, L, Wessely, S, Greenberg, N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–20.CrossRefGoogle Scholar
Vieta, E, Pérez, V, Arango, C. Psychiatry in the aftermath of COVID-19 [in Spanish]. Rev Psiquiatr Salud Ment 2020; 13: 105–10.CrossRefGoogle Scholar
Beards, S, Gayer-Anderson, C, Borges, S, Dewey, ME, Fisher, HL, Morgan, C. Life events and psychosis: a review and meta-analysis. Schizophr Bull 2013; 39: 740–7.CrossRefGoogle ScholarPubMed
Kozloff, N, Mulsant, BH, Stergiopoulos, V, Voineskos, AN. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull 2020; 46: 752–7.CrossRefGoogle Scholar
Valdés-Florido, MJ, López-Díaz, Á, Palermo-Zeballos, FJ, Martínez-Molina, I, Martín-Gil, VE, Crespo-Facorro, B, et al. Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series. Rev Psiquiatr Salud Ment 2020; 13: 90–4.CrossRefGoogle Scholar
Arango, C. Lessons learned from the coronavirus health crisis in Madrid, Spain: how COVID-19 has changed our lives in the last 2 weeks. Biol Psychiatry [Epub ahead of print] 8 Apr 2020. Available from: https://doi.org/10.1016/j.biopsych.2020.04.003.Google Scholar
Bo, HX, Li, W, Yang, Y, Wang, Y, Zhang, Q, Cheung, T, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med 2020.CrossRefGoogle ScholarPubMed
Yao, H, Chen, J-H, Xu, Y-F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 2020; 7: e21.CrossRefGoogle ScholarPubMed
Seminog, OO, Goldacre, MJ. Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies. Thorax 2013; 68: 171–6.CrossRefGoogle ScholarPubMed
Liu, JJ, Bao, Y, Huang, X, Shi, J, Lu, L. Mental health considerations for children quarantined because of COVID-19. Lancet Child AdolescHealth 2020; 4: 347–9.CrossRefGoogle ScholarPubMed
Stefana, A, Youngstrom, EA, Chen, J, Hinshaw, S, Maxwell, V, Michalak, E, et al. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord [Epub ahead of print] 8 Jun 2020. Available from: https://doi.org/10.1111/bdi.12949.CrossRefGoogle Scholar
Lancet Psychiatry. #IAmNotDangerous and the politics of stigma. Lancet Psychiatry 2019; 6: 793.CrossRefGoogle Scholar
Stop the coronavirus stigma now. Nature 2020; 580: 165.CrossRefGoogle Scholar
Kaufman, KR, Petkova, E, Bhui, KS, Schulze, TG. A global needs assessment in times of a global crisis: world psychiatry response to the COVID-19 pandemic. BJPsych Open 2020; 6: 111.CrossRefGoogle ScholarPubMed
Henderson, C, Noblett, J, Parke, H, Clement, S, Caffrey, A, Gale-Grant, O, et al. Mental health-related stigma in health care and mental health-care settings. Lancet Psychiatry 2014; 1: 467–82.CrossRefGoogle ScholarPubMed
Garriga, M, Agasi, I, Fedida, E, Pinzón-Espinosa, J, Vazquez, M, Pacchiarotti, I, et al. The role of mental health home hospitalization care during the COVID-19 pandemic. Acta Psychiatr Scand 2020; 141: 479–80.CrossRefGoogle ScholarPubMed
Shore, JH, Schneck, CD, Mishkind, MC. Telepsychiatry and the coronavirus disease 2019 pandemic-current and future outcomes of the rapid virtualization of psychiatric care. JAMA Psychiatry 11 May 2020 [Epub ahead of print]. Available from: http://doi.org/10.1001/jamapsychiatry.2020.1643CrossRefGoogle ScholarPubMed
Hollander, JE, Carr, BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med 2020; 382: 1679–81.CrossRefGoogle ScholarPubMed
Torous, J, Wykes, T. Opportunities from the coronavirus disease 2019 pandemic for transforming psychiatric care with telehealth. JAMA Psychiatry 11 May 2020. Available from: http://doi.org/10.1001/jamapsychiatry.2020.1640.CrossRefGoogle ScholarPubMed
Hidalgo-Mazzei, D, Murru, A, Reinares, M, Vieta, E, Colom, F. Big Data in mental health: a challenging fragmented future. World Psychiatry 2016; 15: 186–7.CrossRefGoogle ScholarPubMed
Hidalgo-Mazzei, D, Young, AH, Vieta, E, Colom, F. Behavioural biomarkers and mobile mental health: a new paradigm. Int J Bipolar Disord 2018; 6: 9.CrossRefGoogle ScholarPubMed
Hidalgo-Mazzei, D, Llach, C, Vieta, E. mHealth in affective disorders. Int Clin Psychopharmacol 2020; 35: 61–8.CrossRefGoogle ScholarPubMed
Liverpool Drug Interactions Group. Interactions with Experimental COVID-19 Therapies. Liverpool Drug Interactions Group, 2020 (www.covid19-druginteractions.org).Google Scholar
Anmella, G, Arbelo, N, Fico, G, Murru, A, Llach, C, Madero, S, et al. COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry. J Affect Disord 2020; 274: 1062–7.CrossRefGoogle ScholarPubMed
Ministerio de Sanidad. Actualización no 160. Enfermedad por el Coronavirus (COVID-19) [in Spanish]. Ministerio de Sanidad - Gobierno de España, 2020 (https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_160_COVID-19.pdf).Google Scholar
Ministerio de Sanidad. COVID-19 Cumulative Incidences by Provinces in Spain and Epidemiological Week [in Spanish]. Ministerio de Sanidad - Gobierno de España, 2020 (https://cnecovid.isciii.es/covid19/#distribución-geográfica).Google Scholar
Kissler, SM, Tedijanto, C, Goldstein, E, Grad, YH, Lipsitch, M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020; 386: 860–8.CrossRefGoogle Scholar
Figure 0

Fig. 1 The epidemic curve for COVID-19 confirmed cases in Spain according to clinical severity.

n, the cases per day are represented according to the date at the onset of symptoms, date of hospital admission and date of ICU admission, and deaths according to the official dates of death. Each line reports trends with moving averages for 7 days. Source: Informe n° 32. Situación de COVID-19 en España a 21 de mayo de 2020. Equipo COVID-19. Red Nacional de Vigilancia Epidemiológica (RENAVE). Centro Nacional de Epidemiología (CNE). Centro Nacional de Microbiología (CNM). Instituto de Salud Carlos III (ISCIII).11 Data updated on the 21 May 2020.
Figure 1

Fig. 2 Geographical distribution by autonomous community in Spain for the total number of confirmed cases of COVID-19.

Source: data for COVID-19 cases reported by the Spanish Ministry of Health, Consumer Affairs and Social Welfare.12,13 Data updated on the 17 May 2020.
Figure 2

Fig. 3 Daily confirmed COVID-19 cases in Spain (updated on 09 July 2020).

The new daily confirmed cases have been divided into two periods according to approval on 11 May 2020 of the new diagnostic, surveillance and control strategy for the ‘transition’ phase of the COVID-19 pandemic. On the left, the first period (from 1 March 2020 to 10 May 2020) showing daily newly diagnosed cases (by polymerase chain reaction (PCR)) and daily cases with positive immunoglobulin (Ig)G antibodies (presumed immunity). On the right, the second period (from 11 May 2020 ongoing until the time of writing on 13 July 2020) showing daily newly diagnosed cases (by PCR or positive IgM antibodies) divided by symptom presentation. Source: Actualización no 160. Enfermedad por el coronavirus (COVID-19). Ministerio de Sanidad - Gobierno de España.52 Data updated on the 9 July 2020.
Figure 3

Fig. 4 Cumulative incidences by province in Spain for epidemiological week 27 (29 June to 5 July 2020).

After the peak of the pandemic in Spain, lockdown and restriction measures have been progressively withdrawn. The state of emergency expired on 21 June 2020, and each autonomous community has been responsible for the detection and management of COVID-19 resurgences since then, which have been arising continuously. The figure shows the focuses of COVID-19 resurgence during epidemiological week 27. Catalonia, in the north-eastern part of the map, includes four provinces (Barcelona, Lleida, Girona and Tarragona). One of them (Lleida) experienced a COVID-19 resurgence in week 27 (160.72 cases/100 000 compared with 9.04 cases/100 000 in Barcelona in the same week), and restriction measures have been applied accordingly by the Catalan Government. Source: Department of Health. Spanish Government. Red Nacional de Vigilancia Epidemiológica (RENAVE). Centro Nacional de Epidemiología (CNE). Centro Nacional de Microbiología (CNM).54 Data updated on the 10 July 2020.
Supplementary material: File

Pacchiarotti et al. Supplementary Materials

Pacchiarotti et al. Supplementary Materials

Download Pacchiarotti et al. Supplementary Materials(File)
File 6.1 MB
Submit a response

eLetters

No eLetters have been published for this article.